CF
GBIO

Corebridge Financial’s Generation Bio GBIO Stock Holding History

Corebridge Financial’s Portfolio GBIO Stock Details GBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-2,424
Closed -$9.82K – 1072
2025
Q1 		$9.82K Sell
2,424
-36
-1% -$253 ﹤0.01% 2971
2024
Q4 		$26.1K Sell
2,460
-186
-7% -$3.32K ﹤0.01% 2933
2024
Q3 		$65.3K Sell
2,646
-16
-0.6% -$423 ﹤0.01% 2789
2024
Q2 		$75.1K Buy
+2,662
New +$86.5K ﹤0.01% 2756

Other funds holding GBIO

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Corebridge Financial's GBIO Position: Q2 2025 in Review

Corebridge Financial sold out of Generation Bio (GBIO) in Q2 2025, closing a stake of 2,424 shares — an estimated $9.82K sold.

Corebridge Financial first reported a position in GBIO in Q2 2024 and held it in 4 quarters. The position peaked at $75.1K in Q2 2024. 61 funds tracked by Wall St. Rank hold GBIO as of Q2 2025.

  • Corebridge Financial reported no remaining Generation Bio position as of Q2 2025 after selling out during the quarter.
  • Corebridge Financial sold 2,424 Generation Bio shares in Q2 2025, an estimated $9.82K.
  • Corebridge Financial first reported a position in Generation Bio in Q2 2024 and held it in 4 quarters.
  • Corebridge Financial's Generation Bio position peaked at $75.1K in Q2 2024.
  • 61 funds tracked by Wall St. Rank held Generation Bio as of Q2 2025.

Based on Corebridge Financial's 13F filing for Q2 2025, filed 12 Aug 2025.